Peggy L. Porter

University of Washington

Full Professor(heuristic)

Breast Cancer Treatment Studies · Cancer Research

h-index69

i10-index132

Publications216

Citations17,999

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last latest available · showing 13 of 13

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency
JCO Precision Oncology · 2023-09-01 · 6 citations
Supplementary Tables S1-S13 from Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer
2023-03-31
Supplementary Figures S1-S10 from Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast CancerPreprint
2023-03-31
Supplementary Figures S1-S10 from Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast CancerPreprint
2023-03-31
Supplementary Tables S1-S13 from Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer
2023-03-31
Data from Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast CancerPreprint
2023-03-31
Data from Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast CancerPreprint
2023-03-31
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
npj Breast Cancer · 2021-07-26 · 9 citations
Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer
Clinical Cancer Research · 2021-03-22 · 12 citations
FP12.12 Lung Cancer in Women Never-Smokers: A Genomics Perspective of the Women’s Health Initiative (WHI) Cohort.
Journal of Thoracic Oncology · 2021-03-01 · 1 citations
Abstract GS3-05: Classification of triple negative breast cancer (TNBC) by DNA damage immune response (DDIR) signature and homologous recombination deficiency (HRD) status: Analysis of SWOG S9313 adjuvant trial
Cancer Research · 2021-02-15
Abstract P4-10-03: The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations
Cancer Research · 2020-02-15
A24 The Genome-Wide Mutational Landscape of Lung Cancer in Never-Smokers: The Women’s Health Initiative (WHI) Cohort
Journal of Thoracic Oncology · 2020-01-24

Open author page on OpenAlex →